SLNO R&D to Revenue
Soleno Therapeutics Inc · R&D to Revenue
SLNO R&D to Revenue
Latest reported11.92%period ending
SLNO Quarterly R&D/Revenue (23.43% → 11.92%)
Latest values, visible window
High-resolution chart · PNG
SLNO r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 11.9172% | |
| 10.4197% | |
| 12.7314% | |
| 28.0093% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0.1392% | |
| 0% | |
| 97,400% | |
| 375.0943% | |
| 336.097% | |
| 343.769% | |
| 339.3862% | |
| 396.4206% | |
| 531.657% | |
| 1,296.7391% | |
| 3,690.625% | |
| 3,990.9091% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 23.4307% |